NCT02082301View on ClinicalTrials.gov

Oral Glucose Tolerance Testing After Gestational Diabetes

CompletedOBSERVATIONAL
Enrollment

118

Participants

Timeline

Start Date

October 31, 2012

Primary Completion Date

May 4, 2016

Study Completion Date

December 31, 2019

Conditions
Gestational DiabetesPregnancyObesity
Trial Locations (2)

44106

University Hospital, Cleveland

44109

MetroHealth Medical Center, Cleveland

All Listed Sponsors
collaborator

Centers for Disease Control and Prevention

FED

collaborator

Loyola University

OTHER

lead

MetroHealth Medical Center

OTHER

NCT02082301 - Oral Glucose Tolerance Testing After Gestational Diabetes | Biotech Hunter | Biotech Hunter